-
EP2440226
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2440226
| EP2440226 - VACCINE THERAPY FOR CHOROIDAL NEOVASCULARIZATION [Right-click to bookmark this link] | Status | The application has been withdrawn Status updated on 16.10.2015 Database last updated on 29.06.2024 | Most recent event Tooltip | 16.10.2015 | Withdrawal of application | published on 18.11.2015 [2015/47] | Applicant(s) | For all designated states Oncotherapy Science, Inc. 2-1, Sakado 3-chome Takatsu-ku Kawasaki-shi Kanagawa 213-0012 / JP | [2012/16] | Inventor(s) | 01 /
TSUJIKAWA, Motokazu Department of Ophthalmology Osaka University Medical School 2-15 Yamadaoka Suita-shi Osaka 565-0871 / JP | 02 /
NAKAMURA, Yusuke c/o THE UNIVERSITY OF TOKYO 3-1 Hongo 7-chome Bunkyo-ku Tokyo 113-8654 / JP | 03 /
TSUNODA, Takuya c/o ONCOTHERAPY SCIENCE INC. 2-1 Sakado 3-chome Takatsu-ku Kawasaki-shi Kanagawa 213-0012 / JP | [2012/16] | Representative(s) | Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstrasse 3 81675 München / DE | [N/P] |
| Former [2012/16] | Vossius & Partner Siebertstrasse 4 81675 München / DE | Application number, filing date | 10785967.0 | 10.06.2010 | WO2010JP03871 | Priority number, date | JP20090140363 | 11.06.2009 Original published format: JP 2009140363 | [2012/16] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2010143435 | Date: | 16.12.2010 | Language: | EN | [2010/50] | Type: | A1 Application with search report | No.: | EP2440226 | Date: | 18.04.2012 | Language: | EN | The application published by WIPO in one of the EPO official languages on 16.12.2010 takes the place of the publication of the European patent application. | [2012/16] | Search report(s) | International search report - published on: | JP | 16.12.2010 | (Supplementary) European search report - dispatched on: | EP | 19.08.2013 | Classification | IPC: | A61K38/00, A61K39/00, A61P9/00, A61P27/02, A61P35/00, C07K14/71, C12N15/09 | [2012/16] | CPC: |
B60N2/2252 (EP,US);
A61K48/00 (KR);
A61K38/17 (KR);
A61K38/179 (EP,US);
A61K38/18 (KR);
A61K39/0005 (EP,US);
A61P27/02 (EP);
A61P27/10 (EP);
A61P35/00 (EP);
A61P37/04 (EP);
A61P9/00 (EP);
A61P9/10 (EP);
C07K14/00 (US);
C07K14/71 (EP,KR,US);
A61K2039/55566 (EP,US);
A61K38/00 (US)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2012/16] | Title | German: | IMPFSTOFFTHERAPIE ZUR CHOROIDALEN NEOVASKULARISIERUNG | [2012/16] | English: | VACCINE THERAPY FOR CHOROIDAL NEOVASCULARIZATION | [2012/16] | French: | THÉRAPIE PAR VACCIN POUR NÉO-VASCULARISATION CHOROÏDALE | [2012/16] | Entry into regional phase | 05.01.2012 | National basic fee paid | 05.01.2012 | Search fee paid | 05.01.2012 | Designation fee(s) paid | 05.01.2012 | Examination fee paid | Examination procedure | 05.01.2012 | Examination requested [2012/16] | 17.03.2014 | Amendment by applicant (claims and/or description) | 08.10.2015 | Application withdrawn by applicant [2015/47] | Fees paid | Renewal fee | 27.06.2012 | Renewal fee patent year 03 | 20.06.2013 | Renewal fee patent year 04 | 31.03.2014 | Renewal fee patent year 05 | 19.06.2015 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XY]EP1502599 (CT INGENIERIA GENETICA BIOTECH [CU]) [X] 1,2,4,5,7-10,12,13,15 * page 4, paragraph [0024] - page 5 * * page 7, paragraph [0040] - paragraph [0042] * * page 8, paragraph [0049] - paragraph [0053] * * page 9, paragraph [0058] * * claims 1, 13, 14, 18-23, 30, 32, 44, 45, 49-54; table 2 * [Y] 1-15; | [Y]EP1548032 (ONCOTHERAPY SCIENCE INC [JP]) [Y] 1-15 * the whole document *; | [Y]WO2006093030 (ONCOTHERAPY SCIENCE INC [JP], et al) [Y] 1-15 * the whole document *; | [YP]EP2119447 (ONCOTHERAPY SCIENCE INC [JP]) [YP] 1-15 * the whole document *; | [Y] - TAKAHASHI HIDENORI ET AL, "Suppression of choroidal neovascularization by vaccination with epitope peptide derived from human VEGF receptor 2 in an animal model", IOVS, (200805), vol. 49, no. 5, ISSN 0146-0404, pages 2143 - 2147, XP002708485 [Y] 1-15 * the whole document * DOI: http://dx.doi.org/10.1167/iovs.07-0523 | [Y] - MOCHIMARU HIROSHI ET AL, "Suppression of choroidal neovascularization by dendritic cell vaccination targeting VEGFR2", INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, ASSOCIATION FOR RESEARCH IN VISION AND OPHTHALMOLOGY, US, (20071001), vol. 48, no. 10, ISSN 0146-0404, pages 4795 - 4801, XP002576197 [Y] 1-15 * the whole document * | [A] - WADA S ET AL, "Rationale for Antiangiogenic Cancer Therapy with Vaccination Using Epitope Peptides Derived from Human Vascular Endothelial Growth Factor Receptor 2", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, US, (20050601), vol. 65, no. 11, doi:10.1158/0008-5472.CAN-04-3759, ISSN 0008-5472, pages 4939 - 4946, XP002348368 [A] 1-15 * the whole document * DOI: http://dx.doi.org/10.1158/0008-5472.CAN-04-3759 | International search | [Y]US2006234941 (KHLEIF SAMIR N [US], et al); | [Y]JP2008531463 (ONCOTHERAPY SCIENCE, INC.); | [Y]WO2008099908 (UNIV TOKYO [JP], et al); | [X] - GEHLBACH,P. ET AL., "Periocular Gene Transfer of sFlt-1 Suppresses Ocular Neovascularization and Vascular Endothelial Growth Factor-Induced Breakdown of the Blood-Retinal Barrier", HUMAN GENE THERAPY, (2003), vol. 14, no. 2, pages 129 - 141, XP009050097 DOI: http://dx.doi.org/10.1089/104303403321070829 | [X] - ZHANG,M. ET AL., "Recombinant anti-vascular endothelial growth factor fusion protein efficiently suppresses choroidal neovascularization in monkeys", MOLECULAR VISION, (2008), vol. 14, pages 37 - 49, XP008148503 | [X] - UENO, S. ET AL., "Prolonged blockade of VEGF family members does not cause identifiable damage to retinal neurons or vessels", JOURNAL OF CELLULAR PHYSIOLOGY, (2008), vol. 217, no. 1, pages 13 - 22, XP008148067 DOI: http://dx.doi.org/10.1002/jcp.21445 | [A] - NOHOON KWAK ET AL, "VEGF is majour stimulator in model of choroidal neovascularization", INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, (2000), vol. 41, no. 10, pages 3158 - 3164, XP009013972 | [A] - Y MAEDA ET AL., "Detection of peptide-specific CTL-precursors in peripheral blood lymphocytes of cancer patients", BRITISH JOURNAL OF CANCER, (2002), vol. 87, pages 796 - 804, XP002283841 DOI: http://dx.doi.org/10.1038/sj.bjc.6600548 |